Summary
- PRIME was a series of webinars focused on helping advanced NSCLC patients receive comprehensive genomic testing.
- The webinars were hosted by molecular experts and aimed to provide clinical guidance to community pathologists.
- The emphasis was on identifying and solving practice gaps to ensure timely identification of actionable alterations for precision treatments.
- The goal was to help more patients benefit from standard of care precision treatments.
- The content was developed under the direction and sponsorship of Lilly Medical Affairs for US healthcare professionals.
Title: PRIME Webinar Series Aims to Improve Genomic Testing for Lung Cancer Patients
A recent series of webinars called PRIME focused on improving genomic testing for patients with advanced non-small cell lung cancer (NSCLC). The webinars were hosted by experts in molecular testing and aimed to help community pathologists overcome barriers in testing to ensure that all NSCLC patients receive comprehensive genomic testing.
The main goal of the series was to help pathologists identify and address challenges in their workflow to ensure that all actionable alterations are detected promptly. This, in turn, would allow more patients to benefit from precision treatments that are considered the standard of care for NSCLC.
The webinars provided valuable insights and tips for pathologists to improve their testing practices and ensure that all patients have access to the most effective treatments. The series emphasized the importance of timely testing and the impact it can have on patient outcomes.
Overall, the PRIME webinar series was a valuable resource for healthcare professionals looking to enhance their genomic testing practices for NSCLC patients. By addressing testing barriers and improving workflows, more patients can receive the personalized treatments they need to fight their cancer effectively.
Source link
Oncology, Pulmonary Medicine, Pharmacists, Internal Medicine